(Q37043542)

17 August 2017

title

Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting (English)

1 reference

17 August 2017

1 reference

Kerry L LaPlante

1

1 reference

17 August 2017

Tracey L Mersfelder

series ordinal

2

1 reference

17 August 2017

Kristina E Ward

series ordinal

3

1 reference

17 August 2017

Brian J Quilliam

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 January 2008

1 reference

17 August 2017

1 reference

17 August 2017

volume

28

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

82-89

1 reference

Effects of fluoroquinolones on insulin secretion and beta-cell ATP-sensitive K+ channels.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Outpatient gatifloxacin therapy and dysglycemia in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Moxifloxacin and glucose homeostasis: a pooled-analysis of the evidence from clinical and postmarketing studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Standards of medical care in diabetes--2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Management of diabetes and hyperglycemia in hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Possible gatifloxacin-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Severe hyperglycemia during renally adjusted gatifloxacin therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Gatifloxacin therapy associated with hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Severe and persistent hypoglycemia due to gatifloxacin interaction with oral hypoglycemic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Glyburide-ciprofloxacin interaction with resistant hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Refractory hypoglycemia from ciprofloxacin and glyburide interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Fatal hypoglycemia associated with levofloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Glucose homeostasis abnormalities associated with use of gatifloxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

Hypoglycemia in inpatients after gatifloxacin or levofloxacin therapy: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.28.1.82

21 January 2018

Identifiers

DOI

10.1592/PHCO.28.1.82

1 reference

release_hpfzwfgfj5a5pkpbvou7v536d4

17 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hpfzwfgfj5a5pkpbvou7v536d4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference